Identifying the Neural Signature of Exercise to Advance Treatment of PD Cognitive Declines

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Twenty-five participants with PD utilizing the Medtronic Percept PC DBS system will be enrolled for this project and complete a single bout of both FE and VE. The 150-minute experimental session will be completed in the OFF antiparkinsonian and Off-DBS state.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult with a diagnosis of PD by a movement disorders neurologist

• Previous placement, at least six months, of bilateral Medtronic Precept DBS as standard of care treatment for their PD.

• Stable and clinically optimized DBS parameters for three months prior to enrollment.

• Demonstrate the ability to safely mount and dismount a recumbent exercise cycle with an upright back.

• Willingness to withhold antiparkinsonian medication and DBS stimulation.

• Exercise clearance using the American College of Sports Medicine (ACSM) Pre-participation Health Screen: a. If the ACSM screen recommends medical clearance, the subject must obtain medical clearance by their health care provider prior to participation; b. Those who choose not to obtain physician clearance will not be eligible for participation.

Locations
United States
Ohio
Cleveland Clinic
RECRUITING
Cleveland
Contact Information
Primary
MacKenzie Dunlap, BS
dunlapm4@ccf.org
216-219-3949
Backup
Elizabeth Jansen, MPH
aej26@case.edu
216-445-3866
Time Frame
Start Date: 2023-08-15
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 25
Treatments
Experimental: Experimental Arm
Two modes of high intensity exercise.
Related Therapeutic Areas
Sponsors
Leads: The Cleveland Clinic
Collaborators: United States Department of Defense

This content was sourced from clinicaltrials.gov